These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28485090)

  • 41. Rates and Patterns of Australian Emergency Department Presentations of People Who Use Stimulants: A Systematic Literature Review.
    Redona PT; Woods C; Jackson D; Usher K
    Cureus; 2022 Oct; 14(10):e30429. PubMed ID: 36407224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants.
    Kaloyanides KB; McCabe SE; Cranford JA; Teter CJ
    Pharmacotherapy; 2007 May; 27(5):666-74. PubMed ID: 17461701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring pathways into and out of amphetamine type stimulant use at critical turning points: a qualitative interview study.
    Addison M; Kaner E; Spencer L; McGovern W; McGovern R; Gilvarry E; O'Donnell A
    Health Sociol Rev; 2021 Jul; 30(2):111-126. PubMed ID: 34018913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?
    Mackey S; Paulus M
    Neurosci Biobehav Rev; 2013 Mar; 37(3):300-16. PubMed ID: 23253945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimedia educational interventions for consumers about prescribed and over-the-counter medications.
    Ciciriello S; Johnston RV; Osborne RH; Wicks I; deKroo T; Clerehan R; O'Neill C; Buchbinder R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008416. PubMed ID: 23633355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China.
    Zhang Y; Xu Z; Zhang S; Desrosiers A; Schottenfeld RS; Chawarski MC
    J Psychiatr Res; 2014 Jun; 53():99-102. PubMed ID: 24613031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The status quo of amphetamine type stimulants use among residents aged 15-64 in a border city of Yunnan province, 2014].
    Zhang CM; Luo J; Duan L; Yang GG; Li S; Wen PY; Li JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Apr; 40(4):446-450. PubMed ID: 31006206
    [No Abstract]   [Full Text] [Related]  

  • 48. Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine.
    Chintalova-Dallas R; Case P; Kitsenko N; Lazzarini Z
    Int J Drug Policy; 2009 Jul; 20(4):347-51. PubMed ID: 18976896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous analysis of amphetamine-type stimulants in plasma by solid-phase microextraction and gas chromatography-mass spectrometry.
    Mariotti Kde C; Schuh RS; Ferranti P; Ortiz RS; Souza DZ; Pechansky F; Froehlich PE; Limberger RP
    J Anal Toxicol; 2014 Sep; 38(7):432-7. PubMed ID: 25038769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism.
    Todd G; Pearson-Dennett V; Wilcox RA; Chau MT; Thoirs K; Thewlis D; Vogel AP; White JM
    Parkinsonism Relat Disord; 2016 Apr; 25():27-32. PubMed ID: 26923520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal characteristics and pregnancy outcomes among illicit drug-using women in an urban setting.
    Homsup P; Phaloprakarn C; Tangjitgamol S; Manusirivithaya S
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):83-88. PubMed ID: 29458910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does illicit amphetamine seizures quantity associated with amphetamine use disorder related admissions in Saudi Arabia?
    Ramadan M; Ghulam E; Alhusseini N
    BMC Psychiatry; 2023 Jan; 23(1):23. PubMed ID: 36627601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs for stroke recovery: the example of amphetamines.
    Martinsson L; Eksborg S
    Drugs Aging; 2004; 21(2):67-79. PubMed ID: 14960125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescription Stimulants and the Risk of Psychosis: A Systematic Review of Observational Studies.
    Gallagher KE; Funaro MC; Woods SW
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):308-314. PubMed ID: 35489031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 'The Drugs Did For Me What I Couldn't Do For Myself': A Qualitative Exploration of the Relationship Between Mental Health and Amphetamine-Type Stimulant (ATS) Use.
    Spencer LP; Addison M; Alderson H; McGovern W; McGovern R; Kaner E; O'Donnell A
    Subst Abuse; 2021; 15():11782218211060852. PubMed ID: 34898985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.
    Teter CJ; McCabe SE; LaGrange K; Cranford JA; Boyd CJ
    Pharmacotherapy; 2006 Oct; 26(10):1501-10. PubMed ID: 16999660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.